Patent Number: 044141459
Section: claims

1. A method of preparing a non-toxic, pharmaceutically acceptable, .sup.195m Au-containing liquid capable of direct administration in a living being and substantially devoid of .sup.195m Hg ions, wherein the .sup.195m Au is a daughter radioisotope of the .sup.195m Hg ion, comprising: 2. A method according to claim 1 wherein said adsorption agent is selected from the group consisting of activated carbon, silver, hydrated manganese dioxide, and metal sulfides and said eluant is a nontoxic, pharmaceutically acceptable solution which selectively converts .sup.195m Au to an elutable form. 3. A method as set forth in claim 2 wherein the mercury ion-binding material is a metal sulphide. 4. A method as set forth in claim 3 wherein the mercury ion-binding material is a metal sulphide selected from the group consisting of zinc sulphide, zirconium sulphide and silver sulphide. 5. A method as set forth in claims 1, 2, 3, or 4 wherein the adsorption agent contains a substrate material selected from the group consisting of silica gel, aluminum oxide, natural or synthetic aluminum silicate, activated carbon, and glass. 6. A method as set forth in claims 1, 2, 3 or 4 wherein the adsorption agent contains a silica gel substrate material. 7. A method as set forth in claim 1 wherein the adsorption agent contains a substrate material selected from polymers and copolymers of styrene. 8. A method as set forth in claim 1 wherein the adsorption agent comprises particulate substrate material and the mercury ion-binding material is on the surface of the particles of the substrate material. 9. A method as set forth in claim 8 wherein the mercury ion-binding material is selected from the group consisting of hydrated manganese dioxide, metal sulphides and silver. 10. A method as set forth in claim 9 wherein the mercury ion-binding material is a metal sulphide selected from the group consisting of zinc sulphide, zirconium sulphide and silver sulphide. 11. A method as set forth in claim 10, the substrate material is silica gel and the mercury ion-binding material is selected from the group consisting of zinc sulphide and silver sulphide. 12. A method as set forth in claim 11 wherein the adsorption agent comprises silical gel containing about 0.1-20 mg of zinc sulphide per g of silica gel. 13. A method as set forth in claim 12 wherein the adsorption agent comprises silica gel containing about 0.8 to 10 mg of zinc sulphide per g of silica gel. 14. A method as set forth in claim 9 wherein the substrate material is silica gel and the mercury ion-binding material is selected from the group consisting of hydrated manganese dioxide and silver. 15. A method as set forth in claim 8 wherein the substrate material is selected from the group consisting of silica gel, silicate material and glass. 16. A method as set forth in claim 15 wherein the mercury ion-binding material is chemically bonded to the surfaces of the particles of substrate material. 17. A method as set forth in claim 16 wherein the mercury ion-binding material has a terminal functional group selected from the group consisting of thiol-, amino, hydroxy-, carbamate, dithiocarbamate-, xanthate-, and carboxy-functional groups. 18. A method as set forth in claim 8 wherein the mercury ion-binding material is chemically bonded to the surfaces of the particles of substrate material. 19. A method as set forth in claim 18 wherein the mercury ion-binding material has a terminal functional group selected from the group consisting of thiol-, amino-, hydroxy-, carbamate-, dithiocarbamate, xanthate-, and carboxy-functional groups. 20. A method as set forth in claims 1, 2, 8, 11, 15, 18, 16, 19 or 17, wherein the eluant used for the elution of the daughter isotope .sup.195m Au is a pharmaceutically-acceptable solution of a gold ion-complexing agent selected from the group consisting of amines, amino acids and sulphur-containing compounds. 21. A method as set forth in claim 20 wherein the gold ion-complexing agent is selected from the group consisting of thiosulphate, tris(hydroxymethyl)aminomethane, hippurate, glutathione, mercaptopropionyl glycine, thiomalate, thiosalicylate and rhodanide. 22. A method as set forth in claim 21, the eluant is a solution of a gold ion-complexing agent which contains a minor amount of gold carrier. 23. A method as set forth in claim 22 wherein the eluant is a gold ion-complexing agent which contains a dissolved radical scavenger. 24. A method as set forth in claim 23 wherein the radical scavenger is selected from the group consisting of alkali metal nitrates, alkaline earth metal nitrates, alkali metal nitrites and alkaline earth metal nitrites. 25. A method as set forth in claim 20 wherein the eluant is a solution of a gold ion-complexing agent which contains a small amount of gold carrier. 26. A method as set forth in claim 20 wherein the eluant is a solution of a gold ion-complexing agent which contains a dissolved radical scavenger. 27. A method as set forth in claim 26 wherein the radical scavenger is selected from the group consisting of alkali metal nitrates, alkaline earth metal nitrates, alkali metal nitrites and alkaline earth metal nitrites. 28. A method as set forth in claim 18 or 16 wherein the adsorption agent for the parent isotope includes particulate silica gel, the particles of which have at their surface chemically bound groups with thiol functions in the terminal position, and the eluant for the daughter radioisotope is a solution of thiosulphate. 29. A method as set forth in claim 18 or 16 the adsorption agent for the parent isotope includes particulate silica gel, the particles of which have at their surface chemically bound groups having amino functions in the terminal position, and the eluant for the daughter radioisotope is solution of tris(hydroxymethyl)aminomethane. 30. A method as set forth in claim 18 or 16 wherein the mercury ion-binding material is selected from the group consisting of macrocyclic, heteromacrocyclic and polycyclic ligands. 31. A method as set forth in claim 8, 18 or 16 wherein the mercury ion-binding material has been subject to a deactivation treatment so that the material has a reduced adsorption affinity for gold ions. 32. A method as set forth in claim 31 wherein deactivation treatment comprises a chemical reaction selected from substitution, cleavage, condensation and oxidation. 33. A method as set forth in claim 32 wherein the deactivation treatment is an oxidation chemical reaction employing an oxidation agent selected from iodine, bromine, chromic acid and permanganate. 34. A method as set forth in claim 1 wherein the eluant used for the elution of the daughter isotope .sup.195m Au is a pharmaceutically acceptable solution of a gold ion-complexing agent. 35. A method as set forth in claim 34 wherein the solution of gold ion-complexing agent contains a minor amount of gold carrier. 36. A method as set forth in claims 34, 2 or 19 wherein the solution of gold ion-complexing agent contains a dissolved radical scavenger. 37. A method as set forth in claim 36 wherein the radical scavenger is selected from the group consisting of alkali metal nitrates, alkaline earth metal nitrates, alkali metal nitrites and alkaline earth metal nitrites. 38. A method as set forth in claim 37 wherein the radical scavenger is contained in a quantity of about 0.0001-5 wt/vol. % calculated on the quantity of eluant. 39. A method as set forth in claim 38 wherein the radical scanvenger is contained in a quantity of about 0.5-2 wt/vol. % calculated on the quantity of eluant. 40. A method as set forth in claim 8 wherein the adsorption agent for the parent isotope .sup.195m Hg includes particulate silica gel, the particles of which have zinc sulphide at the surface, and the eluant for the daughter radiosotope is a solution of thiosulphate. 41. The method as set forth in claim 8 wherein the adsorption agent for the patent isotope includes particulate silica gel, the particles of which have hydrated manganese dioxide at the surface and the eluant for the daughter radioisotope is a solution of a gold-complexing agent selected from the group consisting of tris(hydroxymethyl)aminomethane and hippurate. 42. A method as set forth in claim 8 wherein the adsorption agent for the present isotope includes particulate silica gel, the particles of which have silver sulphide at the surface, and the eluant for the daughter radioisotope is a solution of a gold-complexing agent selected from the group consisting of glutathione and thiomalate. 43. A method as set forth in claim 8, the adsorption agent the parent isotope includes particulate silica gel, the particles of which have silver at the surface and the eluant for the daughter radioisotope is a solution of a gold complexing agent selected from the group consisting of glutathione, mercaptopropionyl glycine, and thiomalate. 44. A method as set forth in claim 1 wherein .sup.195m Hg is adsorbed on the adsorption agent by contacting the adsorption agent with a solution of .sup.195m Hg ions having a pH of about 1 to about 10. 45. A method as set forth in claim 44 wherein the solution has a pH of about 5 to about 6. 46. A radioisotope generator system for generating a non-toxic, pharmaceutically acceptable .sup.195m Au-containing liquid capable of direct administration in a living being and substantially devoid of .sup.195m Hg ions, wherein the .sup.195m Au is a daughter radioisotope of the .sup.195m Hg ion, comprising: 47. A radioisotope generator system according to claim 46 wherein said adsorption agent is selected from the group consisting of activated carbon, silver, hydrated manganese dioxide, and metal sulfides, and said eluant is a nontoxic, pharmaceutically acceptable solution which selectively converts .sup.195m Au to an elutable form. 48. A radioisotope generator as set forth in claim 47, wherein the column contains sufficient adsorbed .sup.195m Hg to have a radioactivity of about 1-300 mCi. 49. A radioisotope generator as set forth in claim 48 where the column contains sufficient adsorbed .sup.195m Hg to have a radioactivity of about 20-160 mCi. 50. A radioisotope generator as set forth in claim 46 or 47 wherein the generator contains means for directly connecting the generator to a patient. 51. A radioisotope generator as set forth in claim 47 wherein the mercury ion-binding material is a metal sulphide. 52. A radioisotope generator as set forth in claim 51 wherein the mercury ion-binding material is a metal sulphide selected from the group consisting of zinc sulphide, zirconium sulphide and silver sulphide. 53. A radioisotope generator as set forth in claim 46, wherein the generator comprises a reservoir adapted to contain eluant and in communication with the column, means for pumping eluant from the reservoir into the column and forcing the resulting eluant from the column to the body of a patient, means for adding a formulating liquid to the eluate, and a tube connected at one end to the means for adding a formulating liquid and having, at the other end, a member capable of being connected to an auxiliary means for allowing liquid to flow into blood vessels or body cavities of a patient. 54. A radioisotope generator as claimed in claims 46, 53, 47, 51 or 52 wherein the adsorption agent comprises a substrate selected from the group consisting of silica gel, aluminum oxide, natural or synthetic aluminum silicate, activated carbon and glass. 55. A radioisotope generator as set forth in claims 46, 53, 47, 51 or 52 wherein the adsorption agent contains a silica gel substrate material. 56. A radioisotope generator as set forth in claim 46, wherein the adsorption agent contains a substrate material selected from polymers and copolymers of styrene. 57. A radioisotope generator as set forth in claim 46 wherein the adsorption agent contains a particulate substrate material and the mercury ion-binding material is on the surface of the particles of the substrate material. 58. A radioisotope generator as set forth in claim 57 wherein the mercury ion-binding material is selected from the group consisting of hydrated manganese dioxide, metal sulphides and silver. 59. A radioisotope generator as set forth in claim 58 wherein the mercury ion-binding material is a metal sulphide selected from the group consisting of zinc sulphide, zirconium sulphide and silver sulphide. 60. A radioisotope generator as set forth in claim 59 wherein the substrate material is silica gel and the mercury ion-binding material is selected from the group consisting of zinc sulphide and silver sulphide. 61. A radioisotope generator as set forth in claim 60 wherein the adsorption agent comprises silica gel containing about 0.1-20 mg of zinc sulphide per g of silica gel. 62. A radioisotope generator as set forth in claim 61 wherein the adsorption agent comprises silica gel containing about 0.8 to 10 mg of zinc sulphide per g of silica gel. 63. A radioisotope generator as set forth in claim 58 wherein the substrate material is silica gel and the mercury ion-binding material is selected from the group consisting of hydrated manganese dioxide and silver. 64. A radioisotope generator as set forth in claim 57 wherein the substrate material is selected from the group consisting of silica gel, silicate material and glass. 65. A radioisotope generator as is set forth in claims 57 or 64 wherein the mercury ion-binding material is chemically bonded to the surfaces of the particles of substrate material. 66. A radioisotope generator as set forth in claim 65 wherein the mercury-ion binding material contains a function in the terminal position selected from the group consisting of thiol-, amino-, hydroxy-, carbamate-, dithiocarbamate-, xanthate-, and carboxy functions. 67. A radioisotope generator as set forth in claim 65 wherein the adsorption agent for the parent isotope includes particulate silica gel, the particles of which have at their surface chemically bound groups with thiol functions in the terminal position. 68. A radioisotope generator as set forth in claim 65 wherein the adsorption agent for the parent isotope includes particulate silica gel, the particles of which have at their surface chemically-bound groups having amino functions in the terminal position. 69. A radioisotope generator as set forth in claim 65 wherein the adsorption agent contains a mercury ion-binding material selected from the group consisting of macrocyclic, heteromacrocyclic and polycyclic ligands. 70. The radioisotope generator as set forth in claim 57 wherein the adsorption agent for the parent isotope includes particulate silica gel, the particles of which have hydrated manganese dioxide at the surface. 71. A radioisotope generator as set forth in claim 57 wherein the adsorption agent for the parent isotope includes particulate silica gel, the particles of which have silver sulphide at the surface. 72. A radioisotope generator as set forth in claim 57 wherein the adsorption agent for the parent isotope includes particulate silica gel, the particles for which have silver at the surface. 73. An adsorption agent for use in preparing a .sup.195m Au-containing liquid substantially devoid of .sup.195M Hg ions, wherein the .sup.195m Au is a daugher radioisotope comprising a chemically and radiolytically stable mercury ion-binding material having a substantially stronger adsorption affinity for mercury ions than for gold ions and a silica gel substrate material.